Stockreport

Genprex Updates Agreement with University of Texas MD Anderson Cancer Center to Resume Patient Enrollment in Phase I/II Study Evaluating Oncoprex/Erlotinib Combination Therapy in Non-Small...

Genprex, Inc.  (GNPX) 
Last genprex, inc. earnings: 11/14 12:08 pm Check Earnings Report
PDF AUSTIN,Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to tre [Read more]